Pharmacokinetics/pharmacodynamics of lithium in paediatric patients with bipolar disorder: implications for selection of dosage regimens
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: LANDERSDORFER, Cornelia (Monash University, Centre for Medicine Use and Safety, Parkville, Australia)
- Co-author(s): Findling, Robert (Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, md, United States of America)
Taylor-Zapata, Perdita (National Institutes of Health (NIH), Bethesda, md, United States of America)
Kirkpatrick, Carl (Monash University, Parkville, Australia)
Background. Bipolar I disorder (BP-I) leads to substantive psychosocial dysfunction. Lithium is well-established for treating BP-I in adults, however there is a paucity of information in paediatrics.
Aims. To characterise the pharmacokinetics/pharmacodynamics (PK/PD) of lithium in paediatrics and to predict lithium concentrations and clinical.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.